Review: rivastigmine may improve cognitive outcomes in Alzheimer's disease

Bullock, Roger MA, MBBS, MRCPsych

Victoria Hospital Swindon, UK

Birks J, Iakovidou V, Tsolaki M. Rivastigmine for Alzheimer's disease. Cochrane Review, latest version 26 May 1999. In: Cochrane Library. Oxford: Update Software.

Source of funding: Medical Research Council, UK.

For correspondence: Mrs J Birks, Medical Statistician, Department of Geratology, University of Oxford, Oxford OX2 6HE, UK, Fax +44(0)1865 224108.

Evidence-Based Mental Health 3(1):p 10, February 2000.